Fortune August 15, 2022
Moderna’s “next generation” COVID booster, which targets both the original and Omicron strains of the virus, has been cleared for use in adults in the U.K.
The U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA) authorized the booster on Monday.
“We are delighted with the MHRA’s authorization of Spikevax Bivalent Original/Omicron, our next-generation COVID-19 vaccine,” said Stéphane Bancel, CEO of Moderna in a statement. “This bivalent vaccine has an important role to play in protecting people in the U.K. from COVID-19 as we enter the winter months.”
The company says it expects further authorization decisions from other...